GenoFAB Inc.

GenoFAB partners with biotechnology companies and life scientists who need gene delivery solutions. Our clients develop breakthrough genetic medicines targeting challenging diseases that have defeated traditional drug development strategies, including gene therapies, cancer therapies, vaccines, regenerative medicines, and basic research. GenoFAB, through its innovative biofoundry services, engineers unique gene delivery solutions that are tailored to the specific needs of each client's project, setting us apart from standard solutions. Unlike standard gene delivery solutions, GenoFAB's iVectors accelerate product development, streamline the transition to the clinic, and maximize shareholder value by securing defendable intellectual property (IP) positions. GenoFAB, Inc. is a spin-off of Colorado State University (CSU) that has licensed patented technologies developed with funding from the National Institutes of Health, the National Science Foundation, and other federal agencies. Through a contract with CSU, GenoFAB also has access to the services of the Colorado Biofoundry to subcontract part of its clients projects to a high-throughput facility that complements their internal laboratory resources. At GenoFAB, our 'data first' philosophy is more than a belief. It's a strategic approach that underlines the importance of data as a foundational element in the decision-making, development, and operations of R&D projects. This core principle is designed to maximize shareholder value by supporting strong patent claims while ensuring freedom to operate. The GenoFAB patent-pending Biofoundry Operating System is not just a tool. It's a powerful platform that provides unprecedented flexibility, empowering you to manage complex R&D projects. It allows you to define and manage complex workflows that combine experimental steps, computational operations, and supply chain transactions, putting you firmly in control of your projects.